This Direct Meds Consumer Analysis examines oral peptide weight loss formats within the broader context of how shoppers evaluate injectable versus oral GLP-1 administration methods, including the newly available FDA-approved oral semaglutide option, compounded sublingual semaglutide, and compounded sublingual tirzepatide options
Packaging Each product is supplied in a laboratory-grade sealed glass vial , designed to protect the solution from contamination and environmental exposure during storage and transportation
Nevertheless, studies have demonstrated the presence of GLP-1 receptors in both murine and human PanINs 18,22
For the full efficacy picture on each medication, see our semaglutide statistics report and tirzepatide statistics report for 2026
Semaglutide promotes overall body fat reduction, including visceral fat in the abdominal area, which is associated with metabolic health improvements
Such innovations are pivotal in a market where ease of use and patient suitability are increasingly becoming essential determinants in treatment selection